Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
人类
RORA - RAR Related Orphan Receptor A
Alias:
ROR1
ROR2
ROR3
RZRA
NR1F1
RORa1
IDDECA
RORalpha
RZR-ALPHA
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因编码的蛋白质是核激素受体NR1亚家族的成员。它可以作为单体或同型二聚体结合到几个基因上游的激素响应元素,增强这些基因的表达。已表明,编码的蛋白质可以与NM23-2相互作用,NM23-2是一种参与器官发生和分化的核苷酸二磷酸激酶,也可以与NM23-1相互作用,NM23-1是肿瘤转移抑制候选基因的产物。此外,已表明它有助于转录调节一些涉及昼夜节律的基因。已描述了编码不同异构体的四种转录变异体。[RefSeq,2014年2月提供]
Related ID:
NCBI:6095
ENSEMBL:ENSG00000069667
HGNC:10258
UNIPROT:P35398
OMIM:600825
Basic Information
NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
6095
11
11
741019 bp
58.98
119
1
19
32
RORA Genetics information (-)
GRCh38
Sequence Homology
Related Diseases and Mutations
#
Disease
Anatomical Category
Score
Mutations
No data available
Transcripts & Proteins
Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.
Gene Expression
Tissue-specific RNA expression
Organ
Abundance
Alphabetical
Cell-specific RNA expression
Organ
Abundance
Alphabetical
Interactions
Reset
Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available
Related Mouse Models
Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
Link
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top